Biotech is set to go higher after earnings season and could be an investor's chance to play catch-up, says Doug Sandler, of the Riverfront Investment Group; and CNBCs Mike Huckman.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.